Guideline for Management of Vaginal Candidiasis in Prepubertal Girls
Diagnostic Confirmation
- Confirm vaginal candidiasis in prepubertal children with microscopy (KOH preparation) and culture before initiating antifungal therapy, as empiric treatment is inappropriate without objective confirmation. 1, 3
First‑Line Therapy
- Topical antifungal agents are the preferred first‑line treatment for confirmed uncomplicated vaginal candidiasis in children, offering safety and efficacy comparable to oral agents. 1, 2
Recommended Topical Regimens (Uncomplicated Cases)
- Clotrimazole 1 % cream – apply 5 g intravaginally once daily for 7–14 days. 3
- Miconazole 2 % cream – apply 5 g intravaginally once daily for 7 days. 3
- Miconazole 4 % cream – apply 5 g intravaginally once daily for 3 days. 3
- All over‑the‑counter topical agents demonstrate equivalent efficacy; no single formulation has proven superiority. 1, 2, 4
Avoidance of Oral Fluconazole in Children
- Do not use the adult single‑dose oral fluconazole regimen (150 mg) in young children; it lacks pediatric validation and topical therapy minimizes systemic exposure. 1, 2
- Pediatric prescribing should follow pediatric‑specific guidance rather than adult dosing recommendations. 1, 2
Criteria Defining Complicated Infection
- Severe local manifestations – extensive vulvar erythema, edema, excoriation, or fissures. 4
- Recurrent infection – ≥ 4 episodes within a 12‑month period. 4, 5
- Non‑albicans Candida species (e.g., C. glabrata) identified on culture. 4, 5
- Immunocompromised host or presence of underlying medical conditions. 4
Management of Complicated Cases
- Extend topical antifungal therapy to 7–14 days and address any identified predisposing factors (e.g., recent antibiotics, hygiene issues, immunosuppression). 4, 5